PROs in Chronic Low Back Pain Patients With Accompanying Lower Limb Pain (Neuropathic Component) Treated With Pregabalin (PRO)
Patient-reported-outcomes(PROs) in Chronic Low Back Pain Patients With Accompanying Lower Limb Pain (Neuropathic Component) Treated With Pregabalin in Primary Care Settings
연구 개요
상세 설명
Rational and background :
The care for low back pain associated with neuropathic pain is a problem often encountered in daily outpatient.
And the care effectiveness has been frequently evaluated by the patients directly, because the pain would be felt by patients themselves.
On the view of those, we decided to investigate the clinical treatment outcome of pregabalin or other analgesics medication for relief of pain and improvement of sleep interference and QOLs by Patient-reported outcomes.
Research question and objectives :
To evaluate the effect of pregabalin comparing with the conventional analgesic care in chronic low back pain patients with accompanying lower limb pain (neuropathic component) treated in primary care settings under routine clinical practice.
Study design:
This is an 8-week, multicenter prospective observational study. Subjects who have chronic low back pain patients with accompanying lower limb pain (with a neuropathic component) and meet all other entry criteria are enrolled at baseline in the duration of study. The analgesic treatment is determined by the clinical judgment of the physician in charge of patient management. This therapeutic choice is not related to the decision to take part in the study. All enrolled subjects will be received with analgesic treatment. The study requires 3 visits at least, baseline/enrollment visit, Week 4 visit and Week 8 visit (or discontinuation).
연구 유형
등록 (실제)
연락처 및 위치
연구 장소
-
-
-
Kagoshima, 일본
- Nakamura Orthopaedic Clinic
-
Kagoshima, 일본
- Showa-kai Clinic
-
Miyazaki, 일본
- Clinic Ushitani
-
Miyazaki, 일본
- Kohnan Matsumoto Orthopaedic Clinic
-
Saitama, 일본
- Iwasaki Orthopaedic Clinic
-
-
Aichi
-
Nagoya, Aichi, 일본
- Kimura Clinic
-
-
Chiba
-
Ichikawa, Chiba, 일본, 272-0133
- Jin Orthopaedic Clinic
-
Ichikawa, Chiba, 일본
- Satoh Orthopaedic Clinic
-
Ichikawa, Chiba, 일본
- Shiraishi Orthopaedic Clinic
-
-
Kanagawa
-
Kawasaki, Kanagawa, 일본
- Ota General Hospital
-
Sagamihara, Kanagawa, 일본
- Aoki Orthpaedic Clinic
-
Yokohama, Kanagawa, 일본
- Hiyoshi Hocho Clinic
-
Yokohama, Kanagawa, 일본
- Yamamoto Memorial Hospital
-
-
Saitama
-
Ageo, Saitama, 일본
- Ageo Medical Clinic
-
Fujimino, Saitama, 일본
- Arai Orthopaedic Clinic
-
-
Tokyo
-
Adachi, Tokyo, 일본
- Nakaicho Clinic
-
Chiyoda, Tokyo, 일본
- Mitsuda Orthopaedic Clinic
-
Chuo, Tokyo, 일본
- Kyobashi Orthopaedic Clinic
-
Edogawa, Tokyo, 일본
- Morishima Clinic
-
Kita, Tokyo, 일본
- Kita Akabane Orthopaedic Clinic
-
Kita, Tokyo, 일본
- Takeuchi Orthopaedic Clinic
-
Koganei, Tokyo, 일본
- Tanaka Orthopaedic Clinic
-
Koto, Tokyo, 일본
- Araki Clinic
-
Meguro, Tokyo, 일본
- Kohsei Chuo General Hospital
-
Meguro, Tokyo, 일본
- Meguro Seikeigeka Naika
-
Meguro, Tokyo, 일본
- Meguro Yuai Clinic
-
Ohta, Tokyo, 일본
- Takemoto Orthopaedic Clinic
-
Shinagawa, Tokyo, 일본
- Shiotani Pain Clinic
-
Toshima, Tokyo, 일본
- Daido Hospital
-
Toshima, Tokyo, 일본
- Senkawa Shinoda Orthopaedic Clinic
-
Toshima, Tokyo, 일본
- Takahashi Orthopaedic Clinic
-
-
Yokohama
-
Kanazawa, Yokohama, 일본
- Kanazawa Hospital
-
Tsurumi, Yokohama, 일본
- Katayama Orthopaedic Memorial Hospital
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
설명
Inclusion Criteria:
- Subject who received the enough study information and signed informed consent form.
- Subject who had chronic low back pain accompanying with lower limb pain from the knee to the ankle.
- Subject is male or female patient ≥18 years old.
- Subject who has complained low back pain for 3 months or more before Visit 1.
- Subject who is refractory to prior analgesics for 3 months and more.
- Subject who is able and willing to complete all study related assessment and comply with the study schedule and clinical procedures at clinic.
- Subject whose pain Numeric Rating Scale(NRS) ≥ 5 at baseline (based on recall over the past week)
Exclusion Criteria:
- Subject who, in the opinion of the investigator, was not likely to complete the trial for whatever reason.
- Subject who has been already treated by pregabalin
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 관찰 모델: 다른
- 시간 관점: 유망한
코호트 및 개입
그룹/코호트 |
개입 / 치료 |
|---|---|
|
Pregabalin
Patients will be treated for 8 weeks with pregabalin in primary care: no intervention
|
The study is observational
|
|
Usual care
Patients will be treated for 8 weeks with other analgesics in usual care: no intervention
|
The study is observational
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change From Baseline in Pain Related Sleep Interference Scale (PRSIS - Past Week Recall)
기간: Baseline, Final Visit (Week 8)
|
The Pain Related Sleep Interference Scale (past week recall) consists of an 11-point rating scale ranging from 0 (pain did not interfere with sleep) to 10 (pain completely interfered with sleep).
Change the rating scale from baseline to week 8 in each group.
Subjects are to describe how their pain has interfered with their sleep during the past week by choosing the appropriate number between 0 and 10.
|
Baseline, Final Visit (Week 8)
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change From Baseline in Roland Morris Disability Questionnaire (RMDQ)-Total Score-
기간: Baseline, Visit2 (Week4), Final Visit (Week8 or discontinuation)
|
The RMDQ is an index of how well patients with low back pain are able to function with regard to daily activities.
The score for the index ranges from 0 to 24 with a lower score indicating better function.
|
Baseline, Visit2 (Week4), Final Visit (Week8 or discontinuation)
|
|
Change From Baseline in Roland Morris Disability Questionnaire (RMDQ)-Japanese Standardized Score-
기간: Baseline, Visit2 (Week4), Final Visit (Week8 or discontinuation)
|
The RMDQ is an index of how well patients with low back pain are able to function with regard to daily activities.
The score for the index ranges from 0 to 24 with a lower score indicating better function.
|
Baseline, Visit2 (Week4), Final Visit (Week8 or discontinuation)
|
|
Change From Baseline in Pain Numeric Rating Scale (Pain NRS - Past Week Recall)
기간: Baseline, Visit2 (Week4), Final Visit (Week8 or discontinuation)
|
The Pain NRS (past week recall) consists of an 11-point numeric rating scale (NRS) ranging from 0 (no pain) to 10 (worst possible pain).
Subjects are asked to describe their average pain during the past week by choosing the appropriate number between 0 and 10.
|
Baseline, Visit2 (Week4), Final Visit (Week8 or discontinuation)
|
|
Change From Baseline in Euro Qol 5-Dimensions (EQ-5D-5L)-QOL-Score-
기간: Baseline, Visit2 (Week4), Final Visit (Week8 or discontinuation)
|
The EQ-5D-5L is a copyrighted, subject-completed questionnaire designed to assess health-related quality of life in terms of a single index value or utility score.
The Health State Profile is designed to record the subject's level of current health for five domains comprising a health profile: mobility, self-care, usual activities, pain/discomfort and anxiety/depression.
Responses from the five domains are used to calculate a single utility index value.; 1 indicates better health state (no problems); 5 indicates worst health state (eg, "confined to bed").
Scoring formula developed by EuroQol Group assigns a utility value for each domain in the profile; from 11111 to 55555.
Score is transformed and results in a total score range -0.025 to 1.000; higher score indicates a better health state.
|
Baseline, Visit2 (Week4), Final Visit (Week8 or discontinuation)
|
|
Change From Baseline in Euro Qol 5-Dimensions (EQ-5D-5L)-Visual Analogue Scale -
기간: Baseline, Visit2 (Week4), Final Visit (Week8 or discontinuation)
|
The EQ-5D-5L is a copyrighted, subject-completed questionnaire designed to assess health-related quality of life in terms of a single index value or utility score. There are two components to the EQ-5D-5L: A Health State Profile and a Visual Analogue Scale (VAS). Recent guidance suggests that the Health State Profile and VAS should be administered together. The Visual Analogue Scale (VAS) is designed to rate the subject's current health state on a scale from 0 to 100 where 0 represents the worst imaginable health state and 100 represents the best imaginable health state. |
Baseline, Visit2 (Week4), Final Visit (Week8 or discontinuation)
|
|
Clinical Global Impression of Change (CGIC)
기간: Final Visit (Week8 or discontinuation)
|
The CGIC assessment includes one question (1-7 scale) inquiring about the subject's improvement considering their current disease state.; range from 1 (very much improved) to 7 (very much worse).
|
Final Visit (Week8 or discontinuation)
|
|
Patient Global Improvement of Change (PGIC)
기간: Final Visit (Week8 or discontinuation)
|
The PGIC is a subject-rated instrument that measures change in the subject's overall status on a 7-point scale.
Scores range from 1 (very much improved) to 7 (very much worse).
|
Final Visit (Week8 or discontinuation)
|
|
Work Productivity and Activity Impairment Scale (WPAI:LBP)
기간: Final Visit (Week8 or discontinuation)
|
The WPAI: LBP is a self-administered questionnaire that measures the effect of general health and symptom severity on work productivity and regular activities. Subscale scores include Percent work time missed due to pain (PWP), Percent overall work impairment (PWI), Percent work productivity impairment due to pain (PWPI), Percent overall activity impairment (PAI). Each subscale score is expressed as an impairment percentage (0-100) where higher numbers indicate greater impairment and less productivity. Here, "n" signifies "Number of participants" for Baseline. In this study, the WPAI: LBP will measure the effect of the patient's Chronic Low Back Pain (CLBP) with accompanying lower limb pain (neuropathic component) on work productivity and regular activities. |
Final Visit (Week8 or discontinuation)
|
기타 결과 측정
결과 측정 |
기간 |
|---|---|
|
Number of Patients With Adverse Events
기간: Visit2(week4),Final Visit(Week8 or discontinuation)
|
Visit2(week4),Final Visit(Week8 or discontinuation)
|
공동 작업자 및 조사자
수사관
- 연구 책임자: Koichi Fujii, MD, Director of Pain/Neuroscience Medical Affairs,Pfizer Japan Inc.
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .